Colestid and Intervertebral disc degeneration - a phase IV clinical study of FDA data

Summary:

Intervertebral disc degeneration is reported as a side effect among people who take Colestid (colestipol hydrochloride), especially for people who are female, 60+ old, also take Nexium, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Intervertebral disc degeneration when taking Colestid. It is created by eHealthMe based on reports of 2,172 people who have side effects when taking Colestid from the FDA, and is updated regularly.

What is Colestid?

Colestid has active ingredients of colestipol hydrochloride. It is often used in irritable bowel syndrome. eHealthMe is studying from 2,233 Colestid users. Check the latest studies of Colestid.

What is Intervertebral disc degeneration?

Intervertebral disc degeneration (spinal disc degeneration) is found to be associated with 1,316 drugs and 1,493 conditions by eHealthMe. Check the latest studies of Intervertebral disc degeneration.

On Jul, 09, 2026

2,172 people reported to have side effects when taking Colestid.
Among them, 27 people (1.24%) have Intervertebral disc degeneration.

Could Colestid cause Intervertebral disc degeneration?

Among these 27 people:

What is the gender of people who have Intervertebral disc degeneration when taking Colestid? *

female: 92.59 %
male: 7.41 %

What is the age of people who have Intervertebral disc degeneration when taking Colestid? *

What are other drugs people take besides Colestid? *

What are other side effects people have besides Intervertebral disc degeneration? *

Osteoarthritis (a joint disease caused by cartilage loss in a joint): 23 people, 85.19%
Bone Disorder: 23 people, 85.19%
Weight Loss: 22 people, 81.48%
Allergic Rhinitis: 22 people, 81.48%
Chest Pain: 21 people, 77.78%
Exostosis (formation of new bone on the surface of a bone): 18 people, 66.67%
Gastritis (inflammation of stomach): 18 people, 66.67%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 18 people, 66.67%
Muscle Aches (muscle pain): 18 people, 66.67%
Sinus Disorder (disease of sinus): 18 people, 66.67%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 15 people, 55.56%
Osteoporosis (bones weak and more likely to break): 8 people, 29.63%
Osteopenia (a condition where bone mineral density is lower than normal): 8 people, 29.63%
Sleep Disorder: 1 person, 3.70%
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 1 person, 3.70%
Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 1 person, 3.70%
Pain: 1 person, 3.70%
Migraine (headache): 1 person, 3.70%
Lung Cancer Metastatic (lung cancer spreads to other parts): 1 person, 3.70%
Joint Pain: 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Colestid and have Intervertebral disc degeneration?

- Check whether Intervertebral disc degeneration is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Colestid:

Colestid (2,233 reports)

Browse all side effects of Colestid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intervertebral disc degeneration:

Intervertebral disc degeneration (1,316 drugs)

Browse all the conditions that are associated with Intervertebral disc degeneration:

Intervertebral disc degeneration (1,493 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on colestipol hydrochloride (the active ingredients of Colestid) and Colestid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.